SCHEMBL6709985

SCHEMBL6709985

COc1cccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(C#N)cc4-c4noc(=O)[nH]4)[nH]c23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 2/20 0.43
POLB P06746 1/20 0.43
MMP13 P45452 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 5/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
BRAF P15056 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710328 0.94 PARP14 (0.41) PARP14POLBMEN1KMT2ARAB9A
SCHEMBL6707668 0.91 PARP14 (0.43) PARP14POLBMEN1KMT2ARAB9A
SCHEMBL6707955 0.91 PARP14 (0.41) PARP14MEN1KMT2AALDH1A1MAPK8
SCHEMBL6709207 0.91 PARP14 (0.43) PARP14LMNAALDH1A1KDM4EGAA
SCHEMBL6710454 0.90 PARP14 (0.41) PARP14POLBMEN1KMT2ARAB9A
SCHEMBL6710189 0.89 POLB (0.45) PARP14POLBMEN1KMT2ARAB9A
SCHEMBL6710443 0.89 PARP14 (0.41) PARP14POLBMEN1KMT2AMAPT
SCHEMBL6708743 0.89 POLB (0.45) PARP14POLBMEN1KMT2AMAPT
SCHEMBL6710006 0.89 PARP14 (0.41) PARP14POLBMAPTTP53KCNQ2
SCHEMBL6707690 0.89 POLB (0.38) PARP14POLBKMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885POLB 626/4885MMP13 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.